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Tobacco excise tax and children
To the Editor: While the recently promulgated Tobacco
Products Control Act of 1993 has made it an offence to sell
or give cigarettes to children under the age of 16 years,
several studies in South Africa have indicated that children
who begin to smoke do so between the ages of 10 and 12
years.' In the UK, policy makers have recommended that
part of the excise tax collected from children who smoke
should be used to develop health promotion programmes,
particularly programmes aimed at reducing smoking among
teenagers}
To estimate the amount of excise tax received by the
government from children who smoke in South Africa,
published studies carried out since 1988 were used to
estimate smoking rates among children aged 11 - 15 years.
The excise tax rates being applied in 1991 were used.
It was assumed that children who reported smoking more
than 1 cigarette a day on average smoked 2 a day, and that
smoking rates among rural populations were 50% of those
reported in urban studies.
On this basis it was calculated that R10 million per year
is obtained by the Commissioner in the form of excise tax
on cigarettes sold to smokers among South Africa's
approximately 41/2 million 11 - 15-year-olds.
Current investment in health programmes targeting
tobacco control in children constitutes less than 10%
of that amount. The case for earmarking excise tax for
health promotion initiatives was made in' a previous
publication,3 and I emphasise it here. An increase in
excise tax would substantially reduce the likelihood
that children would start smoking and, further, reduce
the amount that they smoke. These funds could ensure
rapid development of comprehensive school-based
education programmes and enable children to make
healthful choices, not only with regard to tobacco use but in
all spheres of their lives.
The recent decision of government to increase excise tax
by only 25% represents a major blow to public health. A
valuable opportunity for prevention has been missed. It is to
be hoped that future budgets will favour public health over
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Proposed Cochrane Collaboration for
tuberculosis treatment
To the Editor: During a meeting of interested persons held at
the International Centre for Health Care Research of the
Karolinska Institute, Stockholm, on 24 and 25 May of this
year a decision was taken to initiate a Cochrane
Collaboration in the field of tuberculosis. This voluntary
collaboration between individuals interested in a particular
field aims to undertake systematic comprehensive reviews
of all published and unpublished randomised controlled
trials of different aspects of tuberculosis therapy. For such a
collaboration to succeed, participants speaking different
languages and with access between them to a wide range
of (often) seldom-read journals is essential. Interested
persons are asked to write to Or Vinod K. Diwan, Karolinska
Institutet, Department of International Health and Social
Medicine, S-171 77 Stockholm, Sweden, stating clearly their
particular field of interest.
P..R. Donald
Department of Paediatrics and Child Health
University of Stellenbosch
Parow, W. Cape
Treating tuberculosis with one
combination drug
To the Editor: We wish to correct certain misconceptions
which could have arisen from the 'Editor's Choice'
commentary' on our recent publication}
1. We compared Rifater (a combined preparation of
isoniazid, rifampicin and pyrazinamide) not simply with the
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same three drugs in separate preparations but with four
drugs (the same three plus ethambutol). It was therefore not
inconceivable that there could have been different clinical
outcomes in the two treatment groups.
2. Criteria for adequate compliance were very strictly
applied. Technically a single dose of treatment could
separate 'compliant' and 'non-compliant' subjects.
Nevertheless, while inadequate compliance was the biggest
single reason for dropping subjects from the study, this
group only constituted 22% of the original 319 admitted to
the study. A further 45% were eliminated for a variety of
other reasons.
3. The population studied was a relatively settled
community in "the Cape Town municipal area. None had had
previous treatment for tuberculosis. The drug resistance rate
of 4,84% therefore applies to this population only. In certain
high-risk groups drug resistance, including multiple
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